| Urinary 8-oxo-7, 8-dihydro-2′-deoxyguanosine analysis by an improved ELISA: An inter-laboratory comparison study P Rossner Jr, H Orhan, G Koppen, K Sakai, RM Santella, A Ambroz, ... Free Radical Biology and Medicine 95, 169-179, 2016 | 34 | 2016 |
| Bioactivation of clozapine by mitochondria of the murine heart: Possible cause of cardiotoxicity E Arzuk, F Karakuş, H Orhan Toxicology 447, 152628, 2021 | 27 | 2021 |
| Accelerated mineralization on nanofibers via non-thermal atmospheric plasma assisted glutamic acid templated peptide conjugation G Onak, O Karaman Regenerative biomaterials 6 (4), 231-240, 2019 | 23 | 2019 |
| Radiolabeled trastuzumab solid lipid nanoparticles for breast cancer cell: in vitro and in vivo studies E Ozgenc, M Karpuz, E Arzuk, M Gonzalez-Alvarez, MB Sanz, ... ACS omega 7 (34), 30015-30027, 2022 | 17 | 2022 |
| Inter-individual and inter-organ variability in the bioactivation of paracetamol by human liver and kidney tissues E Arzuk, B Turna, M Sözbilen, H Orhan Environmental Toxicology and Pharmacology 61, 8-17, 2018 | 14 | 2018 |
| Design, synthesis, and antiproliferative activities of novel thiazolyl-pyrazole hybrid derivatives B Kuzu, A Ergüç, F Karakuş, E Arzuk Medicinal Chemistry Research 32 (8), 1690-1700, 2023 | 9 | 2023 |
| Mitochondrial versus microsomal bioactivation of paracetamol by human liver and kidney tissues E Arzuk, M Tokdemir, H Orhan Toxicology Letters 363, 36-44, 2022 | 7 | 2022 |
| Role of oxidative stress and reactive metabolites in cytotoxicity & mitotoxicity of clozapine, diclofenac and nifedipine in CHO-K1 cells in vitro A Ergüç, F Karakuş, E Arzuk, N Mutlu, H Orhan Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2023 | 5 | 2023 |
| Novel Pyrazole Derivatives Bearing Carbonitrile and Substituted Thiazole Moiety for Selective COX‐2 Inhibition E Arzuk, F Karakuş, A Ergüç, B Kuzu ChemistrySelect 9 (1), e202304783, 2024 | 4 | 2024 |
| Investigation of the role of NLRP3 inflammasome activation in new-generation BCR-ABL1 tyrosine kinase inhibitors-induced hepatotoxicity E Arzuk Toxicology Letters 400, 71-80, 2024 | 1 | 2024 |
| Toxicology of Herbal Medicines H Orhan, E Arzuk, F Karaku, A Ergüç Toxicology for the Health and Pharmaceutical Sciences, 189-220, 2021 | 1 | 2021 |
| In vitro assessment of the role of endoplasmic reticulum stress in sunitinib-induced liver and kidney toxicity E Arzuk, G Armağan Toxicology Letters 403, 9-16, 2025 | | 2025 |
| Genistein and daidzein induce ferroptosis in MDA-MB-231 cells E Arzuk, G Armağan Journal of Pharmacy and Pharmacology 76 (12), 1599-1608, 2024 | | 2024 |
| Matairesinol induced antiproliferative effects via mitochondrial dysfunction in HepG2 cells. E ARZUK, A ERGÜÇ, S DEMİR, NU SOMER, İ TAN, E ATIŞ Journal of Research in Pharmacy 28 (6), 2024 | | 2024 |
| Mitochondrial toxicity of selected natural compounds: in vitro assessment and in silico molecular docking and dynamics simulation A Ergüç, G Albayrak, MT Muhammed, F Karakuş, E Arzuk Drug and Chemical Toxicology, 1-11, 2024 | | 2024 |
| P12-13 Role of endoplasmic reticulum stress in sunitinib-induced hepatotoxicity E Arzuk Toxicology Letters 399, S204-S204, 2024 | | 2024 |
| Celecoxib inhibits NLRP1 inflammasome pathway in MDA-MB-231 Cells E Arzuk, D Birim, G Armağan Naunyn-Schmiedeberg's archives of pharmacology, 1-12, 2024 | | 2024 |
| Mitochondrial Impact of Organophosphate Pesticide-Induced Cardiotoxicity: An In Silico and In Vitro Study F Karakuş, E Arzuk, A Ergüç International Journal of Toxicology, 10915818241261624, 2024 | | 2024 |
| INVESTIGATION OF CYTOTOXIC AND APOPTOTIC EFFECTS OF PRANGOS HEYNIAE H. DUMAN & MF WATSON EXTRACTS ON HEPG2 CELLS PRANGOS HEYNIAE H. DUMAN & MF WATSON EKSTRELERİNİN HEPG2 … E Arzuk, G Albayrak, A Ergüç, E Atiş, İ Tan, Ş Baykan Ankara Universitesi Eczacilik Fakultesi Dergisi 48 (1), 2024 | | 2024 |
| Effect of n-Hexane Extract from Tanacetum argenteum (Lam.) Willd. subsp. argenteum on the Secretion of Proinflammatory Cytokines in THP-1 Cell Line E Arzuk, F Karakuş, G Albayrak, A Ergüç, İ Tan, E Atış Fabad Journal of Pharmaceutical Sciences 49 (1), 233-244, 2024 | | 2024 |
